top of page
shutterstock_1011880639.jpg

INNOVATION

R&D CENTER

콘크리트 벽

R&D VISION

SHAPING THE FUTURE OF MICROBIOME SCIENCE FOR HUMAN WELL-BEING

At Cell Biotech, our R&D vision is deeply rooted in the exploration of microbiome science to advance human health. It all began with the establishment of our Fermentation Microbiology Research Center, setting the stage for pioneering research initiatives.

​

With a relentless pursuit of innovation and collaboration, we've cultivated a forward-looking R&D infrastructure. Collaborating with esteemed institutions worldwide, we actively engage in joint research projects, fostering global partnerships and knowledge exchange.

​

Moreover, we are committed to elevating our global R&D competitiveness and capabilities. This involves expanding our R&D pipeline, exploring biopharmaceutical development, and harnessing cutting-edge technologies like next-generation sequencing.

​

Through our steadfast dedication to scientific exploration and the transformative potential of microbiome science, we're dedicated to making impactful contributions to human health worldwide.

2000~
 

MICROBIOLOGY RESEARCH CENTER

Establishment of lactic acid bacteria fermentation  technology

 

Establishment of R&D base

2010~

 

CELL ENGINEERING RESEARCH INSTITUTE

Securing the best probiotics reseach technology

 

 Reinforcement of R&D capabilities

2020~

 

GLOBAL MICROBIOME R&D CENTER

Globalization of probiotics research capabilities

 

Securing global R&D competitiveness

FROM STRAIN RESEARCH TO CLINICAL TRIALS

INTEGRATED PROBIOTICS RESEARCH INFRASTRUCTURE

Probiotics,as live organisms, undergo deep research conducted by 47 researchers (PhDs, MS) dedicated solely to probiotics at the Cell Biotech R&D center, exploring their safety and functionality through genetic analysis, in vitro, in vivo experiments, and clinical trials This results in evidence based probiotics formulations, with over 200 research achievements

We have established a future-oriented R&D infrastructure, actively conducting joint research projects with overseas institutions. Additionally, we continuously strive to globalize our R&D competitiveness and research capabilities by expanding our R&D pipeline and developing biopharmaceuticals (a new first-in-class colorectal cancer drug) and cosmetics.

image.png

01

PLANNING & ​TARGETING

Targeting the disease and health categoty

02

STRAIN IDENTIFICATION

Whole genome sequencing

03

STRAIN SELECTION

Select the strains with targeted functionality

04

STRAIN FORMULATION

Balanced strain blending

05

EFFICACY VALIDATION

in-vitro, in-vivo, clinical trials

OUR RESEARCH ACHIEVEMENTS

MEET OUR RESEARCH TEAM

PROFESSIONAL PROBIOTICS RESEARCH

Our research teams are composed of passionate experts specializing in various fields to drive innovation and excellence in probiotics, microbiome, and pharmaceutical research.

Driven by a shared passion for scientific discovery and a commitment to excellence, our research team is dedicated to pushing the boundaries of knowledge and innovation in the field of probiotics and microbiome research.

PROBIOTICS & MICROBIOME RESEARCH 

Whole Genome Sequencing (NGS)

Leveraging state-of-the-art Next-Generation Sequencing (NGS) technologies, our team conducts comprehensive analysis of microbial genomes at the strain level.

​

Identifying core and specific genes within each strain, as well as predicting their safety and functionality based on genomic data.


Gut Microbiome

Specialize in the identification and analysis of intestinal microorganisms using advanced data analysis techniques.

​

By exploring the complex ecosystem of the gut microbiome, we gain valuable insights into its composition and functionality.

MICRO-BIOLOGICAL

ENGINEERING

Establishing Strain Library

Curate and maintain a comprehensive strain library to create a database for each strain.

This invaluable resource enables us to access detailed information and characteristics of each strain, facilitating targeted research and development efforts.
 

Developing and Managing Strains

Responsible for developing and managing microbial strains to meet specific research and commercial objectives.

Utilizing advanced biotechnological techniques to modify and enhance strain properties, ensuring optimal performance and functionality.

PHARMA-PROBIOTICS RESEARCH

Development of Anti-Colorectal Cancer Treatment

Pioneering a novel therapeutic approach for colorectal cancer using a P. pentosaceus SL4-based drug delivery system (DDS) equipped with the P8 protein secretion system.

​

This innovative treatment holds promise for improving patient outcomes and addressing unmet medical needs in colorectal cancer therapy.

​

Publishing research papers, investigating mode of action(MOA), and securing patents to advance anti-cancer research.

FORMULATION

DEVELOPMENT

RESEARCH

Streamlined Commercialization

Streamline the process of bringing formulations from concept to market, ensuring efficient commercialization and timely delivery of products.
 

Translating Scientific Data

Leverage proven scientific data to develop formulations that address specific health needs and market demands.

bottom of page